Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2021-11-18 to 2021-11-19
Current total value of award: $8990.4
Description: 4555505734!HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML